References
Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988;12:1573–81.
Mahmarian JJ, Pratt CM, Borges-Neto S, Cashion WR, Roberts R, Verani MS. Quantification of the infarct size by thallium-201 single-photon emission computed tomography during acute myocardial infarction in man: comparison with enzymatic estimates. Circulation 1988;78:831–9.
Sanz G, Castaner A, Betriu A, Magrina J, Roig E, Coll S, et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med 1982:306: 1065–70.
The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309: 331–6.
Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging: a diagnostic tool comes of age. Circulation 1991;83:363–81.
Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischange exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983;68:321–36.
Leppo JA, O'Brien J, Rothendler JA, Getchell JD, Lee VW. Dipyridamole thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984;10:1014–8.
The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasmingen activator in acute myocardial infarction: results of the thrombolytis in myocardial infarction (TIMI) phase II trial. N Engl J med 1989;320:618–27.
The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673–82.
Simoons ML, Vos J, Tijsset JGP, Vermeer F, Verheugt FW, Krauss XH, et al. Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1989;14:1609–15.
Cerqueira MD, Maynard C, Ritchie JL, Davis KB, Kennedy JW, Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials. J Am Coll Cardiol 1992;20:1452–9.
Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocradial infarction measured by quantitative tomographic 99mTc, sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334–41.
Dakik HA, Mahmarian JJ, Kimball KT, Koutelou MG, Medrano R, Verani MS. Prognostic value of exercise thallium-201 tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation 1996. In press.
Mahmarian JJ, Pratt CM, Nishimura S, Abreu A, Verani MS. Quantitative adenosine thallium-201 single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction. Circulation 1993;87:1197–210.
Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol 1995;25:1333–40.
Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation of the use of cardiac procedures after acute myocardial infarction. N Engl J Med 1995;333:573–8.
Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, et al. Treatment of myocardial infarction in the United States (1990 to 1993): observation from the National Registry of Myocardial Infarction. Circulation 1994;90:2103–14.
Spertus JA, Weiss NS, Every NR, Weaver WD, for the Myocardial Infarction Triage and Intervention Project Investigators. The influence of clinical risk factors on the use of angiography and revascularization after acute myocardial infarction. Arch Intern Med 1995;155:2309–16.
Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA 1993;270:1832–6.
Verani MS. Should all patients undergo cardiac catheterization after a myocardial infarction? J Nucl Cardiol 1994;1:S134–46.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verani, M.S. Risk assessment after myocardial infarction: Have the rules changed with thrombolytic therapy?. J Nucl Cardiol 3 (Suppl 6), S50–S59 (1996). https://doi.org/10.1016/S1071-3581(96)90208-1
Issue Date:
DOI: https://doi.org/10.1016/S1071-3581(96)90208-1